About 80 million people in the United States have thinning hair or are bald, according to the American Academy of Dermatology. Experiments to address hair follicles affected by hair loss disorders are under way. While studying treatment options for alopecia areata, a form of hair loss caused by an autoimmune attack on hair follicles, researchers found that two drugs stopped the autoimmune attack and restored hair growth to a few patients. The associate professor of molecular dermatology believes that drugs known as JAK inhibitors have shown promising results in restoring hair growth.
JAK inhibitors are normally used to treat blood diseases and rheumatoid arthritis. Both tofacitinib and ruxolitinib are JAK inhibitors, and they were tested to prove that they induce new hair growth in mice while also causing human hair follicles to grow more hair. The researchers tested the drugs only on…
